loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Trabectedin.

Menu
$ API Ref.Price (USD/KG) : 18,282,028Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Blake Cassels & Graydon LLP

02 2Gowling WLG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Trabectedin

Brand Name : YONDELIS

Patent Number : 2582452

Filing Date : 2005-10-26

Strength per Unit : 1 mg / vial

Dosage Form : Powder for solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2025-10-26

Date Granted : 2010-09-07

blank

02

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Trabectedin

Brand Name : YONDELIS

Patent Number : 2428160

Filing Date : 2001-11-06

Strength per Unit : 1 mg / vial

Dosage Form : Powder for solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2021-11-06

Date Granted : 2009-10-13

blank

03

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Trabectedin

Brand Name : YONDELIS

Patent Number : 2520979

Filing Date : 2005-10-27

Strength per Unit : 1 mg / vial

Dosage Form : Powder for solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2025-10-27

Date Granted : 2009-03-24

blank

04

arrow
Pharmaconex 2024
Not Confirmed
arrow
Pharmaconex 2024
Not Confirmed

Trabectedin

Brand Name : YONDELIS

Patent Number : 2373794

Filing Date : 2000-05-15

Strength per Unit : 1 mg / vial

Dosage Form : Powder for solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2020-05-15

Date Granted : 2005-10-11

blank